Karen Keough

1.1k citations
16 papers · 878 indexed · h-index 10
Topics
Retinal Diseases and Treatments (3 papers)Glaucoma and retinal disorders (3 papers)Metabolism and Genetic Disorders (2 papers)

In The Last Decade

Karen Keough

15 papers receiving 850 citations

Peers

Karen Keough
Comparison fields: 5 of 79
  • Molecular Biology 364
  • Ophthalmology 291
  • Clinical Biochemistry 169
  • Cancer Research 146
  • Radiology, Nuclear Medicine and Imaging 132
Replace Robert Mott with:
Robert Mott United States
HP Hammes Germany
Souska Zandi Switzerland
C. Merges United States
Takeshi Kita Japan
Hye Kyoung Hong South Korea
Tomonari Ojima Japan
Nobuo Jo Japan
Tsung‐Chuan Ho Taiwan
Malika Oubaha Canada
Karen Keough relative to Robert Mott United States Robert Mott's profile →
Citations per field
00.5×1.7×
Robert Mott · 1×
Citations per year

Countries citing papers authored by Karen Keough

Since Specialization
Citations

This map shows the geographic impact of Karen Keough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Keough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Keough more than expected).

Fields of papers citing papers by Karen Keough

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Keough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Keough. The network helps show where Karen Keough may publish in the future.

Co-authorship network of co-authors of Karen Keough

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Keough. A scholar is included among the top collaborators of Karen Keough based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Keough. Karen Keough is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 5
2 4
3 4
4 18
5 5
6 3
7 27
8
Insulin-induced vascular endothelial growth factor expression in retina.
85
9 343
10 105
11 17
12 37
13 20
14 57
15 0
16 148

About Karen Keough

Karen Keough is a scholar working on Clinical Biochemistry, Ophthalmology and Physiology, having authored 16 papers that have together received 878 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (3 papers), Glaucoma and retinal disorders (3 papers) and Metabolism and Genetic Disorders (2 papers). The work is most often cited by research in Ophthalmology (291 citations), Clinical Biochemistry (169 citations) and Immunology and Allergy (66 citations). Karen Keough has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Ming Y. Lu, Anthony P. Adamis, Michael J. Tolentino, Seiji Amano, Manabu Kuroki, Richard Bucala, Judah Folkman, Joseph Shiloach, Thomas Boehm and Robert Shapiro. Their work appears in journals such as Journal of Clinical Investigation, Neurology and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026